Patel M V, O'Brien P Q, Williams B T. "一种的合成方法" [P]. US Patent, US 9243367 B2, 2016-11-06.
Davis P L, Thompson G K, Klinger H. "Method for the Synthesis of methyl[(pyrazin-2-yl)methyl]amine hydrochloride" [P]. US Patent, US 10076925 B2, 2024-06-20.
发明人钱学锋,郑宇鹏,唐晓军. "A Process for Preparing High-Purity methyl[(pyrazin-2-yl)methyl]amine hydrochloride" [P]. 中国发明专利, 专利号 CN 113990150 B, 授权公告日 2017-03-06.
参考文献 Literature
O'Brien K, Kennedy M L. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Molecules, 2023, 1125, (9), 2745-2772.
Lee J H, Choi Y S. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". J. Pharm. Biomed. Anal., 2014, 2008, (6), 5663-5683.
Yamamoto K, Tanaka H, Suzuki T. "Identification and Structural Characterization of a Novel Degradation Product of methyl[(pyrazin-2-yl)methyl]amine hydrochloride Using HRMS and NMR". Rapid Commun. Mass Spectrom., 2019, 1088, 7387-7398.
Kumar A, Sharma P, Patel R S. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". J. Nat. Prod., 2022, 401, (8), 9879-9893.